Company Filing History:
Years Active: 2007
Title: Diti Sangal: Innovator in Insulin Polypeptide-Oligomer Conjugates
Introduction
Diti Sangal is a prominent inventor based in Morrisville, NC (US). She has made significant contributions to the field of biochemistry, particularly in the synthesis of insulin polypeptide-oligomer conjugates. Her innovative work has the potential to impact diabetes treatment and management.
Latest Patents
Diti Sangal holds a patent for "Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same." This patent describes methods for synthesizing proinsulin polypeptides, which include contacting a proinsulin polypeptide with an oligomer to create a proinsulin polypeptide-oligomer conjugate. The process involves cleaving peptides from the conjugate to yield the insulin polypeptide-oligomer conjugate. Additionally, methods for synthesizing C-peptide polypeptide-oligomer conjugates and other pro-polypeptide-oligomer conjugates are also provided.
Career Highlights
Diti Sangal is currently associated with Biocon Limited, a leading biopharmaceutical company. Her work at Biocon focuses on advancing therapeutic solutions for diabetes and other metabolic disorders. With her expertise, she has contributed to the development of innovative treatments that enhance patient care.
Collaborations
Diti collaborates with notable colleagues, including Balasingam Radhakrishnan and Richard Soltero. These partnerships foster a dynamic environment for research and development, leading to groundbreaking advancements in the field.
Conclusion
Diti Sangal's contributions to the field of insulin polypeptide-oligomer conjugates exemplify her dedication to innovation in biochemistry. Her work not only advances scientific knowledge but also holds promise for improving the lives of individuals with diabetes.